Science Explorer Back to mapMap

Most cited papers from Centre for Human Drug Research

What are the most cited papers from Centre for Human Drug Research?

The most cited paper from Centre for Human Drug Research is "HMDB 5.0: the Human Metabolome Database for 2022" (David Scott Wishart et al., 2021), with 2,661 citations. Next come "International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors" (2,575) and "Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates" (1,871).

Showing 50 of 60 papers. Every paper with more than 361 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 HMDB 5.0: the Human Metabolome Database for 2022 David Scott Wishart et al. · Nucleic Acids Research Open access 20 Oct 2021 2,661
2 International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors Bertil B. Fredholm, Adriaan P. IJzerman, Kenneth A. Jacobson et al. · Pharmacological Reviews Open access Dec 2001 2,575
3 Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates Vasco Filipe, Andrea Hawe, Wim Jiskoot · Pharmaceutical Research Open access 3 Mar 2010 1,871
4 The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist Veli‐Pekka Jaakola, Mark T. Griffith, Michael A. Hanson et al. · Science Open access 2 Oct 2008 1,789
5 mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability Linde Schoenmaker, Dominik Witzigmann, Jayesh A. Kulkarni et al. · International Journal of Pharmaceutics Open access 8 Apr 2021 1,561
6 Eleven grand challenges in single-cell data science David Lähnemann et al. · Genome biology Open access 7 Feb 2020 1,493
7 Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0 Laurent Heirendt et al. · Nature Protocols Open access 20 Feb 2019 1,399
8 International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update Bertil B. Fredholm, Adriaan P. IJzerman, Kenneth A. Jacobson et al. · Pharmacological Reviews Open access 15 Feb 2011 1,316
9 Extrinsic Fluorescent Dyes as Tools for Protein Characterization Andrea Hawe, Marc Sutter, Wim Jiskoot · Pharmaceutical Research Open access 3 Jan 2008 1,207
10 Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness Threes G. M. Smijs, Pavel Pavel · Nanotechnology Science and Applications Open access Oct 2011 1,131
11 Multivalent N -Acetylgalactosamine-Conjugated siRNA Localizes in Hepatocytes and Elicits Robust RNAi-Mediated Gene Silencing Jayaprakash K. Nair et al. · Journal of the American Chemical Society Dec 2014 1,126
12 Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition Ruud S. Kootte et al. · Cell Metabolism Open access Oct 2017 1,051
13 Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions Wei Liu, Eugene Chun, Aaron A. Thompson et al. · Science Open access 13 Jul 2012 978
14 Analysis of a sleep-dependent neuronal feedback loop: the slow-wave microcontinuity of the EEG Bob Kemp, Aeilko H Zwinderman, Bert Tuk et al. · IEEE Transactions on Biomedical Engineering 2000 963
15 The Catharanthus Alkaloids:Pharmacognosy and Biotechnology Robert van der Heijden, Denise I. Jacobs, Wim Snoeijer et al. · Current Medicinal Chemistry Mar 2004 733
16 The influence of cytokines on the integrity of the blood-brain barrier in vitro Helga E. de Vries, Margret C.M. Blom-Roosemalen, Marijke van Oosten et al. · Journal of Neuroimmunology 1996 677
17 Maternal Care and Hippocampal Plasticity: Evidence for Experience-Dependent Structural Plasticity, Altered Synaptic Functioning, and Differential Responsiveness to Glucocorticoids and Stress Danielle L. Champagne, Rosemary C. Bagot, F. van Hasselt et al. · Journal of Neuroscience Open access 4 Jun 2008 665
18 Reflections on univariate and multivariate analysis of metabolomics data Edoardo Saccenti, Huub C. J. Hoefsloot, Age K. Smilde et al. · Metabolomics 25 Oct 2013 664
19 Microneedle technologies for (trans)dermal drug and vaccine delivery Koen van der Maaden, Wim Jiskoot, Joke A. Bouwstra · Journal of Controlled Release 4 Feb 2012 653
20 Chitosan-based delivery systems for protein therapeutics and antigens Maryam Amidi, Enrico Mastrobattista, Wim Jiskoot et al. · Advanced Drug Delivery Reviews Review 17 Nov 2009 617
21 Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics Marie A.C. Depuydt et al. · Circulation Research Open access 28 Sep 2020 608
22 Biotechnology for the production of plant secondary metabolites Robert Verpoorte, Adriana Contin, Johan Memelink · Phytochemistry Reviews 2002 604
23 Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality John F. Carpenter, Theodore W. Randolph, Wim Jiskoot et al. · Journal of Pharmaceutical Sciences Open access 14 Aug 2008 593
24 MEMOTE for standardized genome-scale metabolic model testing Christian Lieven et al. · Nature Biotechnology Open access Mar 2020 572
25 Promotion of sleep by targeting the orexin system in rats, dogs and humans Catherine Brisbare‐Roch, Jasper Dingemanse, Ralf Koberstein et al. · Nature Medicine 28 Jan 2007 572
26 The important role of stratum corneum lipids for the cutaneous barrier function Jeroen van Smeden, Michelle Janssens, G.S. Gooris et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 16 Nov 2013 546
27 Screening out irrelevant cell-based models of disease Péter Horváth, Nathalie Aulner, Marc Bickle et al. · Nature Reviews Drug Discovery ReviewOpen access 12 Sep 2016 536
28 Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery Hans Schreier, Joke A. Bouwstra · Journal of Controlled Release Apr 1994 533
29 Addressing the Cold Reality of mRNA Vaccine Stability Daan J.A. Crommelin, Thomas J. Anchordoquy, David B. Volkin et al. · Journal of Pharmaceutical Sciences Open access 13 Dec 2020 531
30 Chitosans for gene delivery Gerrit Borchard · Advanced Drug Delivery Reviews Review Nov 2001 531
31 Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression Pieter Goossens, Juan Rodríguez‐Vita, Anders Etzerodt et al. · Cell Metabolism Open access 28 Mar 2019 524
32 Metabolic network failures in Alzheimer's disease: A biochemical road map Jon B. Toledo et al. · Alzheimer s & Dementia Open access 21 Mar 2017 507
33 Microfluidic 3D cell culture: from tools to tissue models Vincent van Duinen, Sebastiaan J. Trietsch, Jos Joore et al. · Current Opinion in Biotechnology ReviewOpen access 18 Jun 2015 503
34 Small molecule absorption by PDMS in the context of drug response bioassays Berend J. van Meer, Henk J. de Vries, Karl Firth et al. · Biochemical and Biophysical Research Communications Open access 14 Nov 2016 501
35 Measuring thigmotaxis in larval zebrafish Stephanie J. Schnörr, Peter J. Steenbergen, Michael K. Richardson et al. · Behavioural Brain Research 20 Dec 2011 490
36 Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients Michelle Janssens, Jeroen van Smeden, Gert S. Gooris et al. · Journal of Lipid Research Open access Oct 2012 485
37 Nasal mucociliary clearance as a factor in nasal drug delivery Emmeline Marttin, Nicolaas G. M. Schipper, J. Coos Verhoef et al. · Advanced Drug Delivery Reviews Review 1998 469
38 Screening for acetylcholinesterase inhibitors from Amaryllidaceae using silica gel thin-layer chromatography in combination with bioactivity staining In Kyung Rhee, Michiel van de Meent, Kornkanok Ingkaninan et al. · Journal of Chromatography A Apr 2001 468
39 Artificial intelligence for natural product drug discovery Michael W. Mullowney et al. · Nature Reviews Drug Discovery ReviewOpen access 11 Sep 2023 460
40 Chitosan and its derivatives in mucosal drug and vaccine delivery I.M. van der Lubben, J. Coos Verhoef, Gerrit Borchard et al. · European Journal of Pharmaceutical Sciences Oct 2001 450
41 Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels German Chronic Kidney Disease Study et al. · Nature Genetics Open access228 authors Oct 2019 442
42 The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease Alberto Noronha et al. · Nucleic Acids Research Open access 10 Oct 2018 433
43 The Blood-Brain Barrier in Neuroinflammatory Diseases Helga E. de Vries, Johan Kuiper, Albertus Gerrit de Boer et al. · Pharmacological Reviews Jun 1997 433
44 Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system Maryam Amidi, Stefan G. Romeijn, Gerrit Borchard et al. · Journal of Controlled Release 28 Dec 2005 417
45 Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics Thi Huyen Tram Nguyen, M‐S Mouksassi, Nicholas H. G. Holford et al. · CPT Pharmacometrics & Systems Pharmacology Open access 24 Nov 2016 404
46 Fundamentals and developments in fluorescence-guided cancer surgery J. Sven D. Mieog, Friso B. Achterberg, Aimen Zlitni et al. · Nature Reviews Clinical Oncology ReviewOpen access 7 Sep 2021 398
47 Exploration of nature's chemodiversity: the role of secondary metabolites as leads in drug development Robert Verpoorte · Drug Discovery Today May 1998 396
48 The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro Gerrit Borchard, Henrik L. Lueβen, Albertus Gerrit de Boer et al. · Journal of Controlled Release May 1996 395
49 Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum Matthijs Geert Bossong, Bart N.M. van Berckel, Ronald Boellaard et al. · Neuropsychopharmacology 27 Aug 2008 393
50 A metabolic profile of all-cause mortality risk identified in an observational study of 44,168 individuals Joris Deelen et al. · Nature Communications Open access 20 Aug 2019 392

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.